MUCINEX 12HR COLD Drug Patent Profile
✉ Email this page to a colleague
When do Mucinex 12hr Cold patents expire, and when can generic versions of Mucinex 12hr Cold launch?
Mucinex 12hr Cold is a drug marketed by Rb Hlth and is included in one NDA.
The generic ingredient in MUCINEX 12HR COLD is dextromethorphan hydrobromide; guaifenesin; naproxen sodium. There are twenty-three drug master file entries for this compound. Additional details are available on the dextromethorphan hydrobromide; guaifenesin; naproxen sodium profile page.
US Patents and Regulatory Information for MUCINEX 12HR COLD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rb Hlth | MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM | dextromethorphan hydrobromide; guaifenesin; naproxen sodium | TABLET, EXTENDED RELEASE;ORAL | 217338-001 | Dec 22, 2025 | OTC | Yes | Yes | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
